1-55056233-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_174936.4(PCSK9):c.996+44A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.37 ( 16 hom., cov: 0)
Exomes 𝑓: 0.50 ( 880 hom. )
Failed GnomAD Quality Control
Consequence
PCSK9
NM_174936.4 intron
NM_174936.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.84
Publications
0 publications found
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
- hypercholesterolemia, autosomal dominant, 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.52 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PCSK9 | NM_174936.4 | c.996+44A>G | intron_variant | Intron 6 of 11 | ENST00000302118.5 | NP_777596.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PCSK9 | ENST00000302118.5 | c.996+44A>G | intron_variant | Intron 6 of 11 | 1 | NM_174936.4 | ENSP00000303208.5 |
Frequencies
GnomAD3 genomes AF: 0.371 AC: 910AN: 2456Hom.: 15 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
910
AN:
2456
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0211 AC: 175AN: 8282 AF XY: 0.0208 show subpopulations
GnomAD2 exomes
AF:
AC:
175
AN:
8282
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.496 AC: 21218AN: 42746Hom.: 880 Cov.: 0 AF XY: 0.495 AC XY: 9913AN XY: 20042 show subpopulations
GnomAD4 exome
AF:
AC:
21218
AN:
42746
Hom.:
Cov.:
0
AF XY:
AC XY:
9913
AN XY:
20042
show subpopulations
African (AFR)
AF:
AC:
1110
AN:
2162
American (AMR)
AF:
AC:
57
AN:
122
Ashkenazi Jewish (ASJ)
AF:
AC:
141
AN:
568
East Asian (EAS)
AF:
AC:
214
AN:
422
South Asian (SAS)
AF:
AC:
1040
AN:
1900
European-Finnish (FIN)
AF:
AC:
194
AN:
388
Middle Eastern (MID)
AF:
AC:
61
AN:
122
European-Non Finnish (NFE)
AF:
AC:
17576
AN:
35346
Other (OTH)
AF:
AC:
825
AN:
1716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.563
Heterozygous variant carriers
0
857
1715
2572
3430
4287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.371 AC: 912AN: 2458Hom.: 16 Cov.: 0 AF XY: 0.376 AC XY: 437AN XY: 1162 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
912
AN:
2458
Hom.:
Cov.:
0
AF XY:
AC XY:
437
AN XY:
1162
show subpopulations
African (AFR)
AF:
AC:
849
AN:
2066
American (AMR)
AF:
AC:
24
AN:
98
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
72
East Asian (EAS)
AF:
AC:
19
AN:
38
South Asian (SAS)
AF:
AC:
4
AN:
10
European-Finnish (FIN)
AF:
AC:
0
AN:
14
Middle Eastern (MID)
AF:
AC:
0
AN:
4
European-Non Finnish (NFE)
AF:
AC:
7
AN:
126
Other (OTH)
AF:
AC:
7
AN:
30
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
38
77
115
154
192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hypercholesterolemia, familial, 1 Uncertain:1
Mar 01, 2016
Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.